• Price (USD)7.70
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ALS Limited is a global testing, inspection, and certification business. The Company operates under three segments: Commodities, Life Sciences, and Industrial. Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services and related analytical testing. Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments in making informed decisions about environmental, food and pharmaceutical, electronics, and animal health testing matters. The industrial segment provides the energy, resources, transportation and infrastructure sectors with asset care and tribology testing services. It offers services in asset integrity and reliability, environmental and occupational hygiene, mining, and pharmaceutical and healthcare.

  • Revenue in AUD (TTM)2.27bn
  • Net income in AUD263.80m
  • Incorporated1910
  • Employees18.50k
  • Location
    ALS LtdLevel 2, 299 Coronation Drive, MiltonBRISBANE 4064AustraliaAUS
  • Phone+61 73367-7900
  • Fax+61 73367-8156
  • Websitehttps://www.alsglobal.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ALQ:ASX since
Hidro Lab DooDeal completed17 Apr 202317 Apr 2023Deal completed-11.46%--
Data delayed at least 20 minutes, as of Jun 09 2023 07:10 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.